loader from loading.io

JDRF & Beyond Type 1 CEOs Explain Their New Alliance (Bonus Episode)

Diabetes Connections | Type 1 Diabetes

Release Date: 10/16/2019

“How can we continue to move T1D to the background?” Medtronic’s Dr. Jennifer McVean show art “How can we continue to move T1D to the background?” Medtronic’s Dr. Jennifer McVean

Diabetes Connections | Type 1 Diabetes

This week, catching up with Medtronic’s Senior Director of Global Medical Affairs Dr. Jennifer McVean. It’s been one year since the 780G was approved in the US, what does the device – and its seven-day infusion set – look like in the real world. Plus, we have a big discussion about the future of type 1 diabetes – Dr. McVean has lead some significant trials – she lives with type 1 and has some big ideas about changes she’d like to see. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider.   Find out...

info_outline
Meet the newest insulin pump: all about “twiist” with Sequel CEO Alan Lotvin show art Meet the newest insulin pump: all about “twiist” with Sequel CEO Alan Lotvin

Diabetes Connections | Type 1 Diabetes

This week, the newest pump coming to the market is called the twiist. It’s a very different shape – circular with a top half that twists off – with very different software – Tidepool Loop. The company behind this pump – they’re called Sequel - wants to be different as well, hoping to offer solutions to bigger issue than basal and bolus rates. It’s very ambitious and we have a wide ranging conversation about it all with Sequel’s CEO Alan Lotvin This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Our...

info_outline
In the News... Dexcom-to-watch update, Wegovy studies, night time hypo research and more! show art In the News... Dexcom-to-watch update, Wegovy studies, night time hypo research and more!

Diabetes Connections | Type 1 Diabetes

It’s In the News! A look at the top diabetes stories and headlines happening now. Top stories this week: Dexcom launches direct-to-watch with the G7 in the UK and Ireland, more studies looking at heart benefits with Wegovy and diabetes, a new T1D study investigating an injectable to prevent overnight hypoglycemia, lobbying for Levimir, a ChatGPT diabetes diagnosis and more! Find out more about Please visit our Sponsors & Partners - they help make the show possible! Learn more about from extreme temperatures Learn more about Drive The best way to keep up with Stacey and the show...

info_outline
The FDA took down this teen’s free bolus calculator. He needs your help to bring it back. show art The FDA took down this teen’s free bolus calculator. He needs your help to bring it back.

Diabetes Connections | Type 1 Diabetes

There used to be a lot of bolus calculators in the app store, maybe you’ve used one and haven’t updated it in a while. Don’t try now.. it’s likely been pulled. Apple and the FDA are cracking down on this types of tools – no unreasonable, right? But surely there are more coming.. how hard can it be to create a simple insulin bolus calculator that’s FDA approved, easy to find, easy to use, free, and doesn’t require you buy anything else? Turns out, it’s pretty darn hard. We’re talking about that today with the inventor of such an app with an interesting story – he’s still...

info_outline
Diabetes Technology: Expectation vs Reality with Dr. Stephen Ponder show art Diabetes Technology: Expectation vs Reality with Dr. Stephen Ponder

Diabetes Connections | Type 1 Diabetes

Diabetes technology is getting better and better. We have automated insulin systems that link pumps and CGMs, and smart insulin pens that have precise calculations and reminders. It’s been quite the evolution over the past few years! But outcomes – time in range, A1Cs, aren’t exactly where experts thought they might be. I’m talking to Dr. Stephen Ponder about why that is, how a social media post he shared about this caused a strong reaction, and what does work for better long term outcomes. This podcast is not intended as medical advice. If you have those kinds of questions, please...

info_outline
In the News... diabetes drug pricing, vial shortage, pump using Tidepool Loop cleared, insulin cows and more! show art In the News... diabetes drug pricing, vial shortage, pump using Tidepool Loop cleared, insulin cows and more!

Diabetes Connections | Type 1 Diabetes

It's In the News! A look at the top diabetes stories and headlines happening now. Top stories this week: a new study shows that drugs like Ozempic can be produced for just a few dollars, we upate the insulin vial shortage Lilly announced, a new pump has been FDA cleared, a genetically modified cow can product human insulin, and more! Transcript and links below Find out more about  Please visit our Sponsors & Partners - they help make the show possible! Learn more about   from extreme temperatures Learn more about  Drive  The best way to keep up...

info_outline
Answering your questions about Tandem’s new Mobi pump (and more) with Director of Product Marketing Ben Mar show art Answering your questions about Tandem’s new Mobi pump (and more) with Director of Product Marketing Ben Mar

Diabetes Connections | Type 1 Diabetes

Approved last year, Tandem’s Mobi is now widely available. We’re getting an update from Ben Mar, Director of Product Marketing, on the features of the Mobi that make this tiny pump different and we look ahead to what Tandem is working on next. Ben also answers your questions about everything from algorithm updates, international access, and much more This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Find out more about Please visit our Sponsors & Partners - they help make the show possible! Learn more about ...

info_outline
"It needs to be easier" - DIY pioneer Dana Lewis turns her attention to exercise and T1D

Diabetes Connections | Type 1 Diabetes

This week, one of the pioneers of the DIY movement is turning her attention to exercise. Dana Lewis is partnering with other researchers to create a tool to help you make better and easier decisions around whatever workout you choose. There’s a lot of variability here – big difference between say, weight lifting and long distance running – so this is no easy task. Dana will explain the tools they’re using, the big goals here, and we get to catch up about what she’s using these days to manage her life with T1D which now includes ultramarathoning. This podcast is not intended as...

info_outline
In the News... ATTD updates, new CGMs, drops for diabetes eye disease, scholarships and more! show art In the News... ATTD updates, new CGMs, drops for diabetes eye disease, scholarships and more!

Diabetes Connections | Type 1 Diabetes

It's In the News! A look at the top diabetes stories and headlines happening now. Top stories this week: The annual ATTD conference wraps up with news about CGMs, including new FDA approvals and a look at CGMs outside of the US, new eyedrops are being studied to treat diabetic eye disease and Beyond Type 1 opens applications for their annual Beyond Scholars. Transcript and links below Find out more about Please visit our Sponsors & Partners - they help make the show possible! Learn more about from extreme temperatures Learn more about Drive The best way to keep up with Stacey and...

info_outline
Behind the Wheel with T1D: Navigating Teen Driving and Diabetes show art Behind the Wheel with T1D: Navigating Teen Driving and Diabetes

Diabetes Connections | Type 1 Diabetes

Let's talk about driving with diabetes! Getting a driver’s license as a teenager comes with enough challenges without type 1, but letting your child with T1D get behind the wheel is stressful, to say the least! I’m sharing what worked for us and expert advice that may help you and tips to let technology be your friend in the car. This is an excerpt of Stacey's book, "Still the World's Worst Diabetes Mom." It's the second book in her series. You can learn more about the books or on Learn more about that Stacey mentions here. This podcast is not intended as medical advice. If you have...

info_outline
 
More Episodes

What happens when two huge diabetes organizations decide to work together? We're all about to find out. Stacey talks to the CEOs of JDRF & Beyond Type 1 about their newly announced "alliance."

Buy Stacey's Book - "The World's Worst Diabetes Mom"

JDRF's Aaron Kowalski and Beyond Type 1's Thom Scher join Stacey for a talk about why these groups came together and what that means for the diabetes community.

Join the Diabetes Connections Facebook Group!

More info about the announcement here

Sign up for our newsletter here

-----

Use this link to get one free download and one free month of Audible, available to Diabetes Connections listeners!
-----

Get the App and listen to Diabetes Connections wherever you go!

Click here for iPhone      Click here for Android

-----------

Partial transcript of the episode:

Stacey: Can you talk a little bit about the story behind [the alliance]?

Thom: I think that both JDRF and Beyond Type 1 are strong and important in this space. Aaron and I sat down and it was very clear that there were areas of overlap in the middle of the Venn diagram of sorts where we realized that working together, and this sounds a little cheesy, but where it really would be 1+1=3… And the minute we identified that list of things, it just became very clear that we were stronger together on a handful of these initiatives.

 

I also think, and this certainly isn’t something that our organizations were trying to do, but inevitably I think that we, people in the community sometimes feel like they had to pick, and that’s silly. We’re all in this together. We’re all fighting to improve the lives of people impacted by diabetes. I think JDRF and Beyond Type 1 saw that and saw that we were able to really work together and build something robust and official that allows both organizations to now go out and do these things together.

 

Is this a merger? You’ve talked about eliminating some redundancies – can you speak to that?

Aaron: We’re going to stay independent organizations, but it is reducing redundancies and building on what one another do well. From my perspective, when I took on the CEO role of JDRF, I talked to the board about a couple of key things. One is: what is JDRF really good at? I think we’re really good at funding research. We fund more research than anybody but the U.S. government. We’ve been successful at advocacy, and our mission has really been improving lives and curing Type 1 diabetes. Beyond Type 1 has been an incredible force in uniting our community… Beyond Type 1 has engaged with the adult community certainly better than we have.

 

What is the latest from JDRF in terms of pushing for insulin affordability?

Aaron: This is one of our top advocacy issues that we’re dealing with now. I’ve said this multiple times, I’ve testified on the Hill three times on this topic. No one should suffer or die for lack of insulin. And what we have in the United States is a shameful situation. JDRF is fully committed that nobody should have to choose between rent or a car payment or insulin. So we’ve been working on a number of fronts with the payer community, with Congress, looking at people who are under or uninsured, and looking at every remedy possible. I can tell you that working with Beyond Type 1, I think we’re going to be a be able to amplify this message. To me, it’s of course about amplifying the message, but it’s about driving towards solutions.

 

Thom: I’ll build off of that. I think we certainly are looking forward to working with JDRF to be more impactful in this arena of bringing more patient voices into the conversation, certainly at a federal level. I think our perspective at Beyond Type 1 on this is that we need to look for a pragmatic solution. And on top of those pragmatic solutions, we need to be ensuring that we are providing resources every day to people who are in need of insulin. And so some of those pragmatics take the form of actual policy matters be it first dollar coverage or Kevin’s Law. Some of the resource components have to do with ensuring that, for example, people who are uninsured know what assistance programs are available to them, they know how to get to them, they know that with them they will have coverage. There are robust programs in particular for that population. It’s that the barriers to entry are too high. So we’re really committed to building out our advocacy forum of Beyond Type 1 over the course of the next year.

 

This alliance was a big part of that because we now get to work with JDRF, a leading organization on that front, leveraging their expertise and bringing it into our community, and that’s a stepping stone for us to take more meaningful steps.

 

Did you know each other before you started talking about this?

Thom: I consider Aaron a friend, and a colleague, and I love working with him. I don’t think Aaron and I knew each other all that well when we each respectively took over as CEOs, though I certainly knew of Aaron and respected Aaron. I think Aaron and I over series of conversations in person and by phone have definitely gotten closer. I feel really lucky to call Aaron a friend now. I think that certainly informed some of the creation of the alliance. It was Aaron and I being able to really sit down and talk at a high level, everything on the table, how can we work together? That came from a place, at least on my end of [inaudible 00:11:59] Aaron’s vision and a belief that him and I were going to be able to work together and so would our teams. So no, we were not necessarily friends before this, but I certainly consider us friends today.

 

Aaron: Thom came down to the JDRF office in New York City and we sat down and talked, and really, it was quite clear that we were so aligned in where we were trying to take both of these organizations. So we hadn’t met before that and here we are. We took this selfie, and now today in October 2019 I think Thom is a great diabetes friend, and friend just the overall. I always love seeing, we love seeing one another. I mean it’s funny. Diabetes is one of those places I always call it the club that we want no more members of, but you find amazing people who are in this club unfortunately. Thom is just one of those amazing people whose leaned in, he’s just such a joy to work with, and we are going to do amazing things together. I’m just so fortunate that now that we have this bond.